Increasing OXR1 expression has also been shown to delay Lupus-associated induced kidney failure, which is associated with oxidative stress (Li et al., 2014), suggesting OXR1 may have therapeutic applications beyond treating neurodegenerative diseases. The gene discussed is OXR1; the disease is systemic lupus erythematosus.